Abbott Medical Devices

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Abbott Medical Devices sits in the top decile of US sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count).

261 total trials 23 currently recruiting 186 completed later-stage tilt top decile by trial count

Abbott Medical Devices: 261 sponsored US clinical trials, 23 recruiting.

Abbott Medical Devices sponsors 261 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 186 completed. 17 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 15 trials.

Top-decile sponsor footprint

Abbott Medical Devices ranks in the top decile of sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

186 of 211 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

261 total, page 5 of 6

COMPLETED NA

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

NCT00819793
TERMINATED NA

SPIRIT Small Vessel Registry

NCT00783796
COMPLETED

Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication

NCT00743522
COMPLETED NA

Study of New Implantable Loop Recorder

NCT00746564
COMPLETED NA

Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds

NCT00746356
COMPLETED NA

AMPLATZER Duct Occluder II Clinical Study

NCT00713700
COMPLETED

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)

NCT01120379
COMPLETED

Angio-Seal Evolution Device Registry

NCT00817349
COMPLETED

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)

NCT00676520
COMPLETED

Patient Centered Machine Learning Model for Bleeding and Ischemic Risk

NCT06089304
COMPLETED NA

Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study

NCT00647387
TERMINATED NA

Deep Brain Stimulation for Major Depressive Disorder

NCT00617162
TERMINATED NA

Gen2 Isthmus-Dependent Atrial Flutter Ablation Study

NCT00606463
COMPLETED Phase 4

'Effect of CRT on Defibrillation Threshold Estimates' Study

NCT00626093
COMPLETED

Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study

NCT00632372
COMPLETED

EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study

NCT00632450
COMPLETED

St. Jude Medical Product Longevity and Performance (SCORE) Registry

NCT01754064
COMPLETED NA

Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study

NCT00650936
COMPLETED NA

The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis

NCT00490841
COMPLETED NA

Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study

NCT00500838
TERMINATED Phase 1

Dynamic Substrate Mapping (DSM) for Ischemic VT

NCT00558857
COMPLETED NA

Aortic Valve Replacement With Trifecta(TM)

NCT00475709
TERMINATED

AVJ Ablation Followed by Resynchronization Therapy in Patients With CHF and AF

NCT00547794
TERMINATED NA

DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation

NCT00487279
COMPLETED NA

EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant

NCT01615835
COMPLETED NA

Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra

NCT00636987
COMPLETED NA

EVEREST II Pivotal Study High Risk Registry (HRR)

NCT01940120
COMPLETED NA

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)

NCT00402740
COMPLETED

RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population

NCT00837798
COMPLETED NA

FREEDOM - A Frequent Optimization Study Using the QuickOpt Method

NCT00418314
COMPLETED

CHOICE: Carotid Stenting For High Surgical-Risk Patients

NCT00406055
COMPLETED Phase 3

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

NCT00307047
COMPLETED

Lead Registry for Optim Leads

NCT01722188
COMPLETED Phase 4

POWER (Pulse Width Optimized Waveform Evaluation Trial)

NCT00311181
COMPLETED

RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System

NCT00736086
COMPLETED

CAPTURE 2 Post-Marketing Registry

NCT00302237
COMPLETED NA

Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)

NCT00311168
COMPLETED NA

PREMIUM Migraine Trial

NCT00355056
COMPLETED

RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D

NCT00453622
TERMINATED Phase 3

ESCAPE Migraine Trial

NCT00267371
COMPLETED NA

Deep Brain Stimulation (DBS) for the Suppression of Tremor

NCT02087046
COMPLETED NA

Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease

NCT00552474
COMPLETED NA

Pivotal Study of a Percutaneous Mitral Valve Repair System

NCT00209274
COMPLETED Phase 3

RethinQ Study - Evaluating Pacing in Heart Failure Patients

NCT00132977
COMPLETED Phase 4

Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search Study

NCT00187239
COMPLETED Phase 3

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

NCT00180479
COMPLETED Phase 2

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries

NCT00140101
TERMINATED NA

Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)

NCT00106938
COMPLETED NA

Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS)

NCT00547729
COMPLETED NA

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

NCT00121472
← Previous Page 5 of 6 Next →

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 1
Phase 3 11
Phase 4 6

Therapeutic Areas

Heart Failure 15
Coronary Artery Disease 10
Mitral Regurgitation 8
Bradycardia 8
Cardiac Pacemaker 5
Mitral Valve Regurgitation 4
Arrythmia 4
Atrial Fibrillation 4
Cardiac Arrhythmia 3
Cardiac Rhythm Disorder 3

Where Abbott Medical Devices enrollment is open (later-stage tilt)

23 recruiting of 261 indexed (9% open); 186 completed (71%).

Phase mix: 17 late (III/IV) vs 5 early (I/II) (later-stage heavy).

Top condition: Heart Failure (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Abbott Medical Devices: open-pipeline peers nationwide

Peers matched on 261 registered trials and 9% open enrollment, not the therapeutic-area sidebar.

Abbott Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300 0%5%10%15%20%25% Total trials Recruiting share Abbott Medical DevicesPennington Biomedical Research CenterNovartisUniversity of Texas at AustinBoston Medical CenterGrifols TherapeuticsButler HospitalAMAG PharmaceuticalsIowa State University
Abbott Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Abbott Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 261 trials (± recruiting share)

Sponsors near 9% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Abbott Medical Devices page

261 registered trials is a research-attention snapshot, not an endorsement of Abbott Medical Devices or any single study.

  • 23 of Abbott Medical Devices's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Heart Failure is the condition Abbott Medical Devices studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Abbott Medical Devices pipeline card: 261 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.